Facilitate Regulatory Readiness

Adreima provides evidence-based and timely patient status physician recommendations to help hospitals and health systems improve revenue integrity and reimbursement, while maintaining compliance and performance through documentation analysis, improvement and client education. Our solutions include a Physician Second Level Review program, designed specifically to supplement your clinical efforts by providing concurrent, evidence-based recommendation supported by clinical standards and guidelines for documentation surrounding length of stay and patient status. This proven, cost-effective process yields outstanding results for hospitals, including mitigation of denials, quicker access to cash and a clinical staff that is focused on providing quality patient care.

Solutions Provided

Physician Second Level Review

Designed to supplement your clinical efforts, this service provides concurrent, evidence-based recommendations for documentation surrounding length of stay and patient status.

Charge Audits

Our experts recognize discrepancies involving clinical and financial processes and work to strengthen all aspects of a hospital’s charges and charge processes.

Clinical Denials

With a full complement of technical, legal and clinical expertise, Adreima handles denied claims, concurrently and/or retrospectively.

Transfer DRG

Our specialists are trained to apply and interpret CMS guidelines specific to Transfer DRG claims including a triple-check verification process.

Coding Quality Audit

Our audit strategy delivers the tools to understanding clinical areas of potential risk and providing recommendations that improve processes, minimizing future audits and strengthening revenue.

 X
Adreima is pleased to announce that it has been acquired by nThrive. nThrive is a growing industry leader that leverages technology, services, education and analytics to create complete Patient-to-Payment℠ capabilities that our clients need.

Please view our press release for additional information about this exciting acquisition.